How much funding has Ventus Therapeutics raised?

Ventus Therapeutics has raised $360.1M in total funding, most recently a Grant round.

Who are Ventus Therapeutics's investors?

Ventus Therapeutics's investors include SoftBank, Jerel Davis, GV (Google Ventures).

When was Ventus Therapeutics founded?

Ventus Therapeutics was founded in 2019.

Where is Ventus Therapeutics headquartered?

Ventus Therapeutics is headquartered in Montreal, Massachusetts, Canada.

What industry is Ventus Therapeutics in?

Ventus Therapeutics operates in Biotech, Drug Discovery, Therapeutics.

How many employees does Ventus Therapeutics have?

Ventus Therapeutics has 11-50 employees.

Ventus Therapeutics

The Power of Resolution

Montreal, Canada · Founded 2019 · $360.1M raised

Biotech

Drug Discovery

Therapeutics

Headquarters: Montreal, Massachusetts
Employees: 11–50
Founded: 2019
Business Model: B2B

Website: ventustx.com
Total Funding: $360.1M
Last Round: $150K GrantApr 2023
Rounds: 6

About

Ventus Therapeutics is a clinical-stage biopharmaceutical company deploying its proprietary ReSOLVE® platform — combining AI/ML, unrestrained molecular dynamics, and advanced solvation analysis — to discover small-molecule therapeutics for autoimmune, inflammatory, and neurological diseases. The platform enables rapid virtual screening of billions of compounds to identify potent, structurally unique chemical matter, dramatically reducing the time and cost of each drug discovery iteration.

Summary

Ventus Therapeutics is a Biotech company based in Montreal, Canada, founded in 2019. It has raised $360.1M in total across 6 rounds, most recently a $150K Grant round in Apr 2023. Investors include SoftBank, Jerel Davis and GV (Google Ventures).

LinkedIn X (Twitter)